Jan 27, 2023 7:00am EST Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Dec 20, 2022 7:00am EST Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE